First Cited
Last Cited

Articles citing This Document (Page 1 of 2)

Scientific and Regulatory Considerations for Development and Commercialization of Poorly Water-Soluble DrugsAAPS Advances in the Pharmaceutical Sciences Series2022
Pharmacokinetic peculiarities of drugs used in the form of rapidly dispersible tablets (oral delivery system)2020
Scientific and Regulatory Considerations for Development and Commercialization of Poorly Water-Soluble DrugsAAPS Advances in the Pharmaceutical Sciences Series2016
Public Databases and Sources of Information of Interest to Medicinal Chemistry Addiction Researchers
Bioequivalence for Topical Drug ProductsAAPS Advances in the Pharmaceutical Sciences Series2014
Buprenorphine for opioid dependence: Are there really differences between the formulations?Mental Health Clinician2014
Combined Language Processing Methods and Mash-Up System for Improving Retrieval in Diabetes Related PatentsLecture Notes in Computer Science2014
Clinical Endpoint Bioequivalence StudyAAPS Advances in the Pharmaceutical Sciences Series2014
Intellectual Property Protection Strategies for Biotechnology Innovations2020
Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average BioequivalencePharmaceutical Research2020
Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical TrialClinical Pharmacology and Therapeutics2019
Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBaseFundamental and Clinical Pharmacology2019
Patent term restoration for top-selling drugs in the United StatesDrug Discovery Today2019
Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012JAMA Internal Medicine2018
Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014Clinical Pharmacology and Therapeutics2018
The United States of AmericaAAPS Advances in the Pharmaceutical Sciences Series2017
ChinaAAPS Advances in the Pharmaceutical Sciences Series2017
The US Food and Drug Administration's tentative approval process and the global fight against HIVJournal of the International AIDS Society2017
Risk-Based Bioequivalence Recommendations for Antiepileptic DrugsCurrent Neurology and Neuroscience Reports2017
Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation PlatformAAPS PharmSciTech2017
Nanosizing techniques for improving bioavailability of drugsJournal of Controlled Release2017
The global intellectual property ecosystem for insulin and its public health implications: an observational studyJournal of Pharmaceutical Policy and Practice2017
BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO RequirementsAAPS Journal2016
Reducing Illicit Methamphetamine Labs: Is Precursor Control the Answer?Journal of Drug Policy Analysis2016
Which patent and where? Why international patent transparency by companies is needed for medicinesNature Biotechnology2016
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesCirculation2016
Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug AdministrationAddiction2016
Nanodrugs in Medicine and Healthcare: Oral Delivery2016
Could patents interfere with the development of a cardiovascular polypill?Journal of Translational Medicine2016
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabHead and Neck2016
Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?PLoS ONE2016
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugsAsian Journal of Pharmaceutical Sciences2015
SAR and QSAR in Drug Discovery and Chemical Design—Some Examples2015
International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and DifferencesAAPS Journal2015
Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure InfectionsClinical Infectious Diseases2015
Overview of Oral Mucosal DeliveryAdvances in Delivery Science and Technology2015
Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyExperimental Hematology and Oncology2015
Regulatory Requirements for PET Drug ProductionJournal of Nuclear Medicine2014
In vitro dissolution of generic immediate-release solid oral dosage forms containing BCS class I drugs: comparative assessment of metronidazole, zidovudine, and amoxicillin versus relevant comparator pharmaceutical products in South Africa and IndiaAAPS PharmSciTech2014
Role of public standards in the safety and efficacy of biologic medicinesAAPS Journal2014
mTOR inhibitors and their role in modern concepts of immunosuppressionWorld Journal of Surgery2014
Intellectual Property Protection Strategies for Biotechnology Innovations2014
Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed WarningsTherapeutic Innovation and Regulatory Science2014
Regulatory Considerations in Development of Amorphous Solid DispersionsAdvances in Delivery Science and Technology2014
Adverse drug reaction prediction using scores produced by large-scale drug-protein target docking on high-performance computing machinesPLoS ONE2014
Patents associated with high-cost drugs in AustraliaPLoS ONE2013
The future of USP monographs for PET drugsJournal of Nuclear Medicine2013
Pharmaceutical salts: a summary on doses of salt formers from the Orange BookEuropean Journal of Pharmaceutical Sciences2013
Cost Effectiveness of Fracture Prevention in Postmenopausal Women Who Receive Aromatase Inhibitors for Early Breast CancerBreast Diseases2013
Mycophenolate fetal toxicity and risk evaluation and mitigation strategiesAmerican Journal of Transplantation2013